Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment

International Urogynecology Journal

Volumn 21, Issue 1, 2010, Pages 103-109

  Zhang, Qing Hua ^a   Shen, Xue Cheng ^a   Zhou, Zhan Song ^a   Chen, Zhi Wen ^a   Lu, Gen Sheng ^a   Song, Bo ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bladder biopsies; Interstitial cystitis; Nanobacteria; Painful bladder syndrome

Indexed keywords

BACTERIAL RNA; RNA 16S; TETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLADDER BIOPSY; CLINICAL ARTICLE; CYSTOSCOPY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INTERSTITIAL CYSTITIS; MICROBIAL GROWTH; NANOBACTERIA; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT RESPONSE; URINE CULTURE;

EID: 74049120223     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-009-0994-7     Document Type: Article

References (30)

1. DR Erickson JE Tomaszewski AR Kunselman, et al. 2008 Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome J Urol 179 1850 1856 10.1016/j.juro.2008.01.047 18353383
2. CW Butrick D Sanford Q Hou JD Mahnken 2009 Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations Int Urogynecol J Pelvic Floor Dysfunct 20 1047 1053 10.1007/s00192-009-0897-7 19458891
3. GJ Domingue GM Ghoniem KL Bost C Fermin LG Human 1995 Dormant microbes in interstitial cystitis J Urol 153 1321 1326 10.1016/S0022-5347(01)67594-3 1:STN:280:DyaK2M7nsVWgtA%3D%3D 7869536
4. S Keay RS Schwalbe AL Trifillis JC Lovchik S Jacobs JW Warren 1995 A prospective study of microorganisms in urine and bladder biopsies from interstitial cystitis patients and controls Urology 45 223 229 10.1016/0090-4295(95)80009-3 1:STN:280:DyaK2M7lvFaqsw%3D%3D 7855970
5. MA Bratos-Pérez PL Sánchez S García de Cruz, et al. 2008 Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification Eur Heart J 29 371 376 10.1093/eurheartj/ehm592 18192703 (Pubitemid 351197757)
6. N Ciftcioglu EO Kajander 1998 Interaction of nanobacteria with cultured mammalian cells Pathophysiology 4 259 270 10.1016/S0928-4680(97)10001-3 (Pubitemid 28085561)
7. EO Kajander N Ciftcioglu 1998 Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation Proc Natl Acad Sci U S A 95 8274 8279 10.1073/pnas.95.14.8274 1:CAS:528:DyaK1cXks1SltLk%3D 9653177 (Pubitemid 28326103)
8. N Ciftçioglu M Björklund K Kuorikoski K Bergström EO Kajander 1999 Nanobacteria: an infectious cause for kidney stone formation Kidney Int 56 1893 1898 10.1046/j.1523-1755.1999.00755.x 10571799 (Pubitemid 29518191)
9. Z Zhou L Hong X Shen, et al. 2008 Detection of nanobacteria infection in type III prostatitis Urology 71 1091 1095 10.1016/j.urology.2008.02.041 18538692 (Pubitemid 351763790)
10. HM Wood DA Shoskes 2006 The role of nanobacteria in urologic disease World J Urol 24 51 54 10.1007/s00345-005-0041-3 16402263
11. JW Warren LM Horne JR Hebel RP Marvel SK Keay TC Chai 2000 Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis J Urol 163 1685 1688 10.1016/S0022-5347(05)67520-9 1:STN:280:DC%2BD3c3lvFKisw%3D%3D 10799160
12. FC Burkhard N Blick WW Hochreiter UE Studer 2004 Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol 172 232 235 10.1097/01.ju.0000128698.93305.2e 15201781
13. N Cíftçíoglu MA Miller-Hjelle JT Hjelle EO Kajander 2002 Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method Antimicrob Agents Chemother 46 2077 2086 10.1128/AAC.46.7.2077-2086.2002 12069958 (Pubitemid 34665900)
14. JY Gillenwater AJ Wein 1988 Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987 J Urol 140 203 206 1:STN:280:DyaL1c3ksFCgsg%3D%3D 3379688
15. M Drancourt P Berger D Raoult 2004 Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans J Clin Microbiol 42 2197 2202 10.1128/JCM.42.5.2197-2202.2004 1:CAS:528:DC%2BD2cXkvFOjt7Y%3D 15131188 (Pubitemid 38637841)
16. DA Shoskes KD Thomas E Gomez 2005 Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience J Urol 173 474 477 10.1097/01.ju.0000150062.60633.b2 15643213
17. L Kushner RM Moldwin 2006 Efficiency of questionnaires used to screen for interstitial cystitis J Urol 176 587 592 10.1016/j.juro.2006.03.035 16813894 (Pubitemid 43927888)
18. M Drancourt V Jacomo H Lepidi, et al. 2003 Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones J Clin Microbiol 41 368 372 10.1128/JCM.41.1.368-372.2003 12517874 (Pubitemid 36098601)
19. K Benzerara VM Miller G Barell, et al. 2006 Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy J Investig Med 54 367 379 10.2310/6650.2006.06016 1:CAS:528:DC%2BD2sXisValuro%3D 17169258 (Pubitemid 46123031)
20. J Martel JD Young 2008 Purported nanobacteria in human blood as calcium carbonate nanoparticles Proc Natl Acad Sci U S A 105 5549 5554 10.1073/pnas.0711744105 1:CAS:528:DC%2BD1cXkslSntrg%3D 18385376 (Pubitemid 351753900)
21. D Raoult M Drancourt S Azza, et al. 2008 Nanobacteria are mineralo fetuin complexes PLoS Pathog 4 e41 10.1371/journal.ppat.0040041 18282102 (Pubitemid 351340707)
22. JD Young J Martel D Young, et al. 2009 Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria PLoS One 4 e5421 10.1371/journal.pone.0005421 19412552
23. SB Prusiner 1997 Prion diseases and the BSE crisis Science 278 245 251 10.1126/science.278.5336.245 1:CAS:528:DyaK2sXms1Cqs7w%3D 9323196 (Pubitemid 27450864)
24. N Ciftcioglu KM Aho DS McKay EO Kajander 2007 Are apatite nanoparticles safe? Lancet 369 2078 10.1016/S0140-6736(07)60977-5 17586302 (Pubitemid 46935942)
25. JT Hjelle MA Miller-Hjelle IR Poxton, et al. 2000 Endotoxin and nanobacteria in polycystic kidney disease Kidney Int 57 2360 2374 10.1046/j.1523-1755.2000.00096.x 1:CAS:528:DC%2BD3cXkt1CgtbY%3D 10844606 (Pubitemid 30340735)
26. N Ciftçioǧlu McKay Ds EO Kajander 2003 Association between nanobacteria and periodontal disease Circulation 108 e58 59 10.1161/01.CIR.0000086781.16968.2D 12939248
27. T Tsurumoto D Zhu AP Sommer 2008 Identification of nanobacteria in human arthritic synovial fluid by method validated in human blood and urine using 200 nm model nanoparticles Environ Sci Technol 42 3324 3328 10.1021/es702857s 1:CAS:528:DC%2BD1cXktFSgsrs%3D 18522113
28. DP Eisen IR Fraser LM Sung M Finlay S Bowden H O'Connell 2009 Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment Clin Infect Dis 48 e86 88 10.1086/597827 1:CAS:528:DC%2BD1MXlsFWlu78%3D 19292661
29. EO Kajander N Ciftcioglu MA Miller-Hjelle JT Hjelle 2001 Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease Curr Opin Nephrol Hypertens 10 445 452 10.1097/00041552-200105000-00023 1:STN:280:DC%2BD3Mzps1Wntw%3D%3D 11342811 (Pubitemid 32424037)
30. EM Little C Holt 2004 An equilibrium thermodynamic model of the sequestration of calcium phosphate by casein phosphopeptides Eur Biophys J 33 435 447 10.1007/s00249-003-0376-x 1:CAS:528:DC%2BD2cXmtFWltro%3D 14735250